California Nanotechnologies Corp. (CNO) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Earth Alive Clean Technologies, Inc.

Rapid Dose Therapeutics Corp.

Avicanna, Inc.

Microbix Biosystems, Inc.

California Nanotechnologies Corp.

Ceapro, Inc.

Cardiol Therapeutics, Inc.

Medicenna Therapeutics Corp.

FSD Pharma, Inc.

Hemostemix, Inc.

Cognetivity Neurosciences Ltd.

Why is California Nanotechnologies Corp. ?

The company has declared negative results in Nov 24 after 5 consecutive negative quarters

NET SALES(HY) At CAD 1.62 MM has Grown at -64.58%
OPERATING CASH FLOW(Y) Lowest at CAD 0.02 MM
ROCE(HY) Lowest at -110.37%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -61.97%, its profits have fallen by -451%

Underperformed the market in the last 1 year

Even though the market (S&P/TSX 60) has generated returns of 23.72% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -61.97% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is California Nanotechnologies Corp. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

California Nanotechnologies Corp.

-61.97%

8.63

100.14%

S&P/TSX 60

23.72%

1.55

15.31%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

31.16%

EBIT Growth (5y)

-211.20%

EBIT to Interest (avg)

0.62

Debt to EBITDA (avg)

1.05

Net Debt to Equity (avg)

-0.09

Sales to Capital Employed (avg)

2.30

Tax Ratio

24.17%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

39.85%

ROE (avg)

25.88%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.90

EV to EBIT

-5.18

EV to EBITDA

-8.05

EV to Capital Employed

4.95

EV to Sales

3.41

PEG Ratio

Dividend Yield

ROCE (Latest)

-95.41%

ROE (Latest)

-120.99%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

DEBT-EQUITY RATIO (HY)

Lowest at 49.14 %

-33What is not working for the Company

NET SALES(HY)

At CAD 1.62 MM has Grown at -64.58%

OPERATING CASH FLOW(Y)

Lowest at CAD 0.02 MM

ROCE(HY)

Lowest at -110.37%

PRE-TAX PROFIT(Q)

Lowest at CAD -1.52 MM

RAW MATERIAL COST(Y)

Grown by 338.42% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.49 times

OPERATING PROFIT(Q)

Lowest at CAD -0.91 MM

NET PROFIT(Q)

Lowest at CAD -1.53 MM

EPS(Q)

Lowest at CAD -0.03

Here's what is working for California Nanotechnologies Corp.

Debt-Equity Ratio

Lowest at 49.14 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for California Nanotechnologies Corp.

Net Sales

At CAD 1.62 MM has Grown at -64.58%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (CAD MM)

Pre-Tax Profit

At CAD -1.52 MM has Fallen at -207.48%

over average net sales of the previous four periods of CAD -0.49 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CAD MM)

Net Profit

At CAD -1.53 MM has Fallen at -175.2%

over average net sales of the previous four periods of CAD -0.55 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CAD MM)

Pre-Tax Profit

Lowest at CAD -1.52 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CAD MM)

Operating Cash Flow

Lowest at CAD 0.02 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CAD MM)

Operating Profit

Lowest at CAD -0.91 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CAD MM)

Net Profit

Lowest at CAD -1.53 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CAD MM)

EPS

Lowest at CAD -0.03

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CAD)

Debtors Turnover Ratio

Lowest at 3.49 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 338.42% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales